Zuellig paid 2.6 billion won of royalty to head office last year.

Published: 2006-03-31 06:56:00

Updated: 2006-03-31 06:56:00

Zuellig Pharma Korea reported the royalty payment to the head office, Zuellig Pharma Holdings. Ltd. at 2,640 million won on charge of the marketing and information services. (3,100 MW in 2004 and 2,635 MW in 2003). Zuellig Korea is a 95% stock owned company by Zuellig Pharma Holdings Ltd.

Zue...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK